F9 Malmo, factor IX and deep vein thrombosis

• Published in: Haematologica (Roma) Vol. 94; no. 5; pp. 693 - 699
• Main Authors: Bezemer, Irene D, Arellano, Andre R, Tong, Carmen H, Rowland, Charles M, Ireland, Helen A, Bauer, Kenneth A, Catanese, Joseph, Reitsma, Pieter H, Doggen, Carine J.M, Devlin, James J, Rosendaal, Frits R, Bare, Lance A
• Format: Journal Article
• Language: English
• Published: Pavia Ferrata Storti Foundation 01.05.2009
• Subjects: Adolescent; Adult; Aged; Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Case-Control Studies; Chromosomes, Human, X - genetics; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous; Factor IX - genetics; Factor IX - metabolism; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Hematologic and hematopoietic diseases; Humans; Linkage Disequilibrium; Male; Medical sciences; Middle Aged; Odds Ratio; Original; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis - blood; Venous Thrombosis - genetics; Young Adult; Genetic variability; Hematology; Deep vein thrombosis; Cardiovascular disease; Genotype; Venous disease; Vascular disease; Factor IX; Blood vessel; Venous thrombosis; Circulatory system; Single nucleotide polymorphism; Vein
• ISSN: 0390-6078; 1592-8721; 1592-8721
• DOI: 10.3324/haematol.2008.003020

1 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 2 Celera, Alameda, CA, USA 3 Department of Cardiovascular Genetics, Division of Medicine, University College London, London, UK 4 Beth Israel Deaconess Medical Center, Molecular Medicine Unit, Boston, MA, USA 5 Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands 6 Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, the Netherlands Correspondence: Frits R. Rosendaal, Department of Clinical Epidemiology, C7-P Leiden University Medical Center P.O. Box 9600 2300 RC Leiden, The Netherlands. E-mail: f.r.rosendaal{at}lumc.nl Background: We recently reported the association between the Malmö sequence variant in F9 (rs6048) and deep vein thrombosis. Design and Methods: We aimed to study whether the association between F9 Malmö and deep vein thrombosis is explained by linkage disequilibrium with nearby single-nucleotide polymorphisms, and whether the association is explained biologically by F9 Malmö affecting factor IX antigen levels or activation of factor IX. We investigated the association of F9 Malmö and 28 nearby single-nucleotide polymorphisms with deep vein thrombosis in men from two case-control studies, LETS (n=380) and MEGA (n=1,469). We assessed the association of F9 Malmö with factor IX antigen level in male control subjects from LETS (n=191) and two subsets of MEGA (n=823 and n=484) and the association with endogenous thrombin potential in LETS control men. We studied the association between F9 Malmö and factor IX activation peptide in 1,199 healthy middle-aged men from the NPHS-II cohort. Results: In the combined LETS and MEGA studies, the odds ratio (95% confidence interval) for the G allele of F9 Malmö, compared with the A allele, was 0.80 (0.69–0.93). One single-nucleotide polymorphism in F9 , rs422187 , was strongly linked to F9 Malmö (r 2 =0.94) and was similarly associated with deep vein thrombosis. No other single-nucleotide polymorphism or haplotype tested was more strongly associated. Factor IX antigen level, factor IX activation peptide levels and endogenous thrombin potential did not differ between F9 Malmö genotypes. Conclusions: The F9 Malmö sequence variant was the most strongly associated with deep vein thrombosis among common single-nucleotide polymorphisms in the region. However, the biological mechanism by which F9 Malmö affects risk remains unknown. Key words: factor IX, single nucleotide polymorphism, venous thrombosis. Related Article Factor IX and deep vein thrombosis Gordon Lowe Haematologica 2009 94: 615-617. [Full Text] [PDF]